Table 2 Awareness of PrEP and other prevention strategies, and comfort with HIV/STI procedures among HIV physicians from Brazil and Mexico, 2020
| Â | Total | Brazil | Mexico | P valuea |
|---|---|---|---|---|
(N = 481) n (%) | (N = 339; 70.5%) n (%) | (N = 142; 29.5%) n (%) |  | |
Awareness of PrEP and other prevention strategies (yes) | ||||
 PEP | 419 (87.1) | 302 (89.1) | 117 (82.4) | .05 |
 Combination HIV prevention concept | 407 (84.6) | 294 (86.7) | 113 (79.6) | .05 |
 Condoms and lubricants | 407 (84.6) | 303 (89.4) | 104 (73.2) | <.001 |
 PrEP | 407 (84.6) | 291 (85.8) | 116 (81.7) | .25 |
 Regular HIV/STI testing | 393 (81.7) | 299 (88.2) | 94 (66.2) | <.001 |
 Mother to child transmission | 371 (77.1) | 286 (84.4) | 85 (59.9) | <.001 |
 Knowledge of partner serology | 356 (74) | 275 (81.1) | 81 (57) | <.001 |
 Treatment as prevention | 347 (72.1) | 280 (82.6) | 67 (47.2) | <.001 |
 Vaccination for HAVb, HBVc and HPVd | 335 (69.7) | 270 (79.6) | 65 (45.8) | <.001 |
 Cervical exams | 233 (48.4) | 185 (54.6) | 48 (33.8) | <.001 |
Awareness of PrEP Technologies (yes) | ||||
 Daily oral with TDF/FTCe | 444 (92.3) | 313 (92.3) | 131 (92.3) | .98 |
 Event-Driven PrEP with TDF/FTCe | 262 (54.5) | 212 (62.5) | 50 (35.2) | <.001 |
 Daily oral with TAF/FTCf | 246 (51.1) | 171 (50.4) | 75 (52.8) | .63 |
 Cabotegravir injection | 202 (42) | 180 (53.1) | 22 (15.5) | <.001 |
 Vaginal ring with antiretroviral | 156 (32.4) | 120 (35.4) | 36 (25.4) | .03 |
 Microbicides | 104 (21.6) | 82 (24.2) | 22 (15.5) | .03 |
 Implants with antiretroviral | 97 (20.2) | 81 (23.9) | 16 (11.3) | <.01 |
 Monoclonal antibodies | 61 (12.7) | 57 (16.8) | 4 (2.8) | <.001 |
Comfort with HIV/STI prevention procedures (yes) | ||||
 Request HIV exam | 477 (99.2) | 337 (99.4) | 140 (98.6) | .36 |
 Request STI exams | 473 (98.3) | 335 (98.8) | 138 (97.2) | .20 |
 Evaluation of sexual risk behavior | 458 (95.2) | 324 (95.6) | 134 (94.4) | .57 |
 Risk-reduction counseling | 458 (95.2) | 317 (93.5) | 141 (99.3) | <.01 |
 Discuss sexual behavior | 454 (94.4) | 320 (94.4) | 134 (94.4) | .99 |
 Discuss sexual orientation | 453 (94.2) | 317 (93.5) | 136 (95.8) | .33 |
 Provide HIV+ result | 441 (91.7) | 310 (91.5) | 131 (92.3) | .77 |
 Evaluation of PrEP eligibility | 432 (89.8) | 301 (88.8) | 131 (92.3) | .25 |
 U=Ug counseling | 387 (80.5) | 274 (80.8) | 113 (79.6) | .75 |
 Request HIV acute infection testh | 333 (69.2) | 333 (98.2) | – | N/Ai |
 Evaluation of PEP eligibilityh | 320 (66.5) | 320 (94.4) | – | N/A |